Literature DB >> 21342898

Perspective: Swine-origin influenza: 1976 and 2009.

David J Sencer1.   

Abstract

I am in a unique situation, having been involved in 2 major US public health events resulting from novel swine-origin influenza viruses. In 1976, I was Director of the Center for Disease Control (CDC, the name of the agency at the time) when a new influenza virus, characterized as an influenza A(H1N1) swine virus, was isolated from military recruits at Fort Dix, New Jersey. Subsequently, I led the CDC through the US response to this outbreak, which culminated in the decision to implement the swine flu vaccination program during which 45 million people were vaccinated over 10 weeks. The program was stopped after cases of Guillain-Barré Syndrome were identified following vaccination and when no spread of the virus occurred beyond Fort Dix. In 2009, as another new swine H1N1 virus was first identified and emergency response began, I was asked to be an advisor to the CDC Director in order that I might provide historical context to the novel H1N1 swine-origin outbreak and response. In this latter capacity, I have been able to observe and participate in discussions resulting in decision-making for the CDC's national response to this public health emergency as an unpaid consultant. This paper is a personal commentary on the similarities and dissimilarities of the 2 episodes.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21342898     DOI: 10.1093/cid/ciq006

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  8 in total

1.  Challenges and changes: immunization program managers share perspectives in a 2012 national survey about the US immunization system since the H1N1 pandemic response.

Authors:  Katherine Seib; Allison Chamberlain; Katelyn Wells; Eileen Curran; Ellen As Whitney; Walter A Orenstein; Alan R Hinman; Saad B Omer
Journal:  Hum Vaccin Immunother       Date:  2014       Impact factor: 3.452

2.  The Protein Maker: an automated system for high-throughput parallel purification.

Authors:  Eric R Smith; Darren W Begley; Vanessa Anderson; Amy C Raymond; Taryn E Haffner; John I Robinson; Thomas E Edwards; Natalie Duncan; Cory J Gerdts; Mark B Mixon; Peter Nollert; Bart L Staker; Lance J Stewart
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2011-08-13

3.  Simultaneous identification of DNA and RNA viruses present in pig faeces using process-controlled deep sequencing.

Authors:  Jana Sachsenröder; Sven Twardziok; Jens A Hammerl; Pawel Janczyk; Paul Wrede; Stefan Hertwig; Reimar Johne
Journal:  PLoS One       Date:  2012-04-13       Impact factor: 3.240

4.  Responding to vaccine safety signals during pandemic influenza: a modeling study.

Authors:  Judith C Maro; Dennis G Fryback; Tracy A Lieu; Grace M Lee; David B Martin
Journal:  PLoS One       Date:  2014-12-23       Impact factor: 3.240

5.  Glycosylation of Hemagglutinin and Neuraminidase of Influenza A Virus as Signature for Ecological Spillover and Adaptation among Influenza Reservoirs.

Authors:  Paul Kim; Yo Han Jang; Soon Bin Kwon; Chung Min Lee; Gyoonhee Han; Baik Lin Seong
Journal:  Viruses       Date:  2018-04-07       Impact factor: 5.048

6.  Use of Hemagglutinin Stem Probes Demonstrate Prevalence of Broadly Reactive Group 1 Influenza Antibodies in Human Sera.

Authors:  Hadi M Yassine; Patrick M McTamney; Jeffery C Boyington; Tracy J Ruckwardt; Michelle C Crank; Maria K Smatti; Julie E Ledgerwood; Barney S Graham
Journal:  Sci Rep       Date:  2018-06-05       Impact factor: 4.379

7.  Announcing Swine Flu and the Interpretation of Pandemic Anxiety.

Authors:  Jonathan Everts
Journal:  Antipode       Date:  2012-07-19

8.  The epidemiology and surveillance response to pandemic influenza A (H1N1) among local health departments in the San Francisco Bay Area.

Authors:  Wayne T A Enanoria; Adam W Crawley; Winston Tseng; Jasmine Furnish; Jeannie Balido; Tomás J Aragón
Journal:  BMC Public Health       Date:  2013-03-27       Impact factor: 3.295

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.